Please use this identifier to cite or link to this item: https://doi.org/10.1016/S0959-8049(99)00057-X
DC FieldValue
dc.titleAntitumour immunity of Bacillus Calmette-Guerin and interferon alpha in murine bladder cancer
dc.contributor.authorGan, Y.H.
dc.contributor.authorZhang, Y.
dc.contributor.authorKhoo, H.E.
dc.contributor.authorEsuvaranathan, K.
dc.date.accessioned2011-11-30T06:34:30Z
dc.date.available2011-11-30T06:34:30Z
dc.date.issued1999
dc.identifier.citationGan, Y.H., Zhang, Y., Khoo, H.E., Esuvaranathan, K. (1999). Antitumour immunity of Bacillus Calmette-Guerin and interferon alpha in murine bladder cancer. European Journal of Cancer 35 (7) : 1123-1129. ScholarBank@NUS Repository. https://doi.org/10.1016/S0959-8049(99)00057-X
dc.identifier.issn09598049
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/29480
dc.description.abstractIntravesical Bacillus Calmette-Guerin (BCG) immunotherapy is currently the optimal choice for aggressive superficial bladder cancer, with a 70% response rate. This study investigated whether the antitumour response elicited by BCG could be improved by the addition of recombinant interferon alpha (IFNα) in the subcutaneous murine MB49 bladder tumour model. The combination of BCG and IFNα had superior and earlier antitumour activity than BCG alone for MB49 cells in culture. A total of 14/15 BCG plus interferon-treated mice and 8/16 BCG-treated mice became tumour free after treatment. BCG or the combination treatment significantly raised the T- helper 1 (Th1) cytokine IFNγ levels compared with levels in all other groups. Whilst BCG therapy alone increased CD4+ and CD8+ populations in spleens, the combination of BCG and IFNα also increased αβ+ T cells significantly. Our results suggest that the combination of BCG and IFNα may represent a more efficacious therapeutic than BCG alone for superficial bladder cancer.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/S0959-8049(99)00057-X
dc.sourceScopus
dc.subjectBacillus Calmette-Guerin
dc.subjectBladder cancer
dc.subjectImmunotherapy
dc.subjectInterferon alpha
dc.typeArticle
dc.contributor.departmentSURGERY
dc.contributor.departmentBIOCHEMISTRY
dc.description.doi10.1016/S0959-8049(99)00057-X
dc.description.sourcetitleEuropean Journal of Cancer
dc.description.volume35
dc.description.issue7
dc.description.page1123-1129
dc.description.codenEJCAE
dc.identifier.isiut000081739300022
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

26
checked on Apr 15, 2021

WEB OF SCIENCETM
Citations

23
checked on Apr 15, 2021

Page view(s)

209
checked on Apr 14, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.